http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0278629-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09ef68d5f101548ce2f633f4ef72cad9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L77-00
filingDate 1988-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf14c56d6c5925e462c0d36985d14ea8
publicationDate 1990-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0278629-A
titleOfInvention Medical composition
abstract PURPOSE: To obtain a medical composition having excellent compatibility with drug and excellent biodegradation by reacting a polymer of lactic acid and/or glycolic acid with polyethylene glycol to give a copolymer as a base and adding polypeptide to the base. n CONSTITUTION: A polymer or copolymer (one having 400-5,000 number-average molecular weight is used) of lactic acid and/or glycolic acid is melted under heating at 100-250°C, softening point thereof. Then the melted polymer or copolymer is reacted with polyethylene glycol (one having 200-2,000 number-average organic is used) under a nitrogen gas introduction to give a copolymer. Then copolymer is used as a base and mixed with polypeptide. In blending, for example, an aqueous solution or hydrogel of the copolymer is mixed with powder of an aqueous solution of the polypeptide. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6201072-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572340-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006023388-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004215712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7135190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000237297-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5702717-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1276505-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5209687-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665428-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642502-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100754550-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6117949-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293531-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008139804-A1
priorityDate 1988-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63218632-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01163135-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364031

Total number of triples: 41.